Absence of severe COVID-19 in patients with clonal mast cells activation disorders: effective anti-SARS-CoV-2 immune response.
J. Rossignol, A. Ouedrani, C. Bulai-Livideanu…·Mania
The paper investigates the immune response in patients with clonal mast cells activation disorders (cMCADs) during SARS-CoV-2 infection and finds no severe COVID-19 cases and robust anti-viral immunity.